Corcept ALS Drug Shows Significant Survival Benefit Despite Missed Primary Endpoint
Corcept Therapeutics Incorporated (NASDAQ:CORT) is one of the best mid cap growth stocks to invest in now.
Corcept Therapeutics Inc (CORT)
Market is closed
Sector: Pharmaceutical Preparations
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Renaissance Technologies Jim Simons | 6,143,031 | $701,657,001 | -1% | 1.06% |
| 2. | Arrowstreet Capital Peter Rathjens, Bruce Clarke And John Campbell | 1,492,227 | $170,442,168 | -10% | 0.14% |
| 3. | D E Shaw D. E. Shaw | 700,264 | $79,984,154 | -22% | 0.07% |
| 4. | GLG Partners Noam Gottesman | 629,175 | $71,864,369 | +119% | 0.18% |
| 5. | 403,900 | $46,133,458 | 0.43% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $21.53 | 100,000 | $2,153,000.00 | 3,308,303 | 2021-06-11 | Filing | |
| $21.53 | 50,000 | $1,076,500.00 | 1,046,838 | 2021-06-11 | Filing | |
| $22.64 | 68 | $1,539.52 | 3,208,303 | 2020-12-01 | Filing | |
| $22.80 | 1,109 | $25,285.20 | 3,208,235 | 2020-11-30 | Filing | |
| $22.81 | 361 | $8,232.79 | 3,207,126 | 2020-11-25 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $70.77 | 3,185 | $225,402.45 | 13,364 | 2025-06-16 | Filing | |
| $70.61 | 2,200 | $155,342.00 | 0 | 2025-06-10 | Filing | |
| $72.75 | 3,082 | $224,213.65 | 5,487 | 2025-06-10 | Filing | |
| $72.36 | 16,918 | $1,224,260.92 | 8,569 | 2025-06-10 | Filing | |
| $85.01 | 8,408 | $714,777.53 | 2,901,985 | 2025-06-02 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 14,688,410 | $1,677,710,190 | 0.04% | |
| 2. | 9,981,968 | $1,140,140,386 | 0.02% | |
| 3. | 3,401,936 | $388,569,130 | 0.02% | |
| 4. | 2,260,063 | $258,989,226 | 0.02% | |
| 5. | 2,136,510 | $243,708,402 | 0.06% |
News See All
11 Best Mid Cap Growth Stocks To Invest In Now
On June 18, Scott Wren, Wells Fargo senior global market strategist, joined CNBC's 'Closing Bell Overtime' to talk about how the market sell-off is an opportunity to step in.
Why Corcept Therapeutics Incorporated (CORT) Crashed On Monday
We recently published a list of These 10 Stocks Already Sank in June.
Corcept Therapeutics Incorporated (CORT)’s Reports Promising Phase 3 Results for Ovarian Cancer Drug
Corcept Therapeutics Incorporated (NASDAQ:CORT) is making headlines after its Phase 3 ROSELLA trial showed relacorilant, combined with nab-paclitaxel, reduced disease progression risk by 30% in platinum...
11 Best Performing Healthcare Stocks to Buy Now
On April 15, CNBC reported that President Trump's healthcare-focused executive order brought in a win for the sector.
Corcept Therapeutics Incorporated (NASDAQ:CORT) Q1 2025 Earnings Call Transcript
Corcept Therapeutics Incorporated (NASDAQ:CORT) Q1 2025 Earnings Call Transcript May 5, 2025Corcept Therapeutics Incorporated reports earnings inline with expectations.
Billionaire Jim Simons' RenTech's 10 Small-Cap Stock Picks with Huge Upside Potential
Jim Simons was (and still is even after his death in May 2024) one of the biggest names – if not the biggest – in the hedge fund space.
15 Best Growth Stocks to Buy for the Next 3 Years
On April 29, Dan Ives of Wedbush Securities joined 'Power Lunch' on CNBC to discuss his outlook for the tech sector and expressed that tariffs aren't stopping the AI revolution.
11 Best Guru Stocks to Buy According to Wall Street Analysts
Wall Street seems to be breathing a little easier after the initial panic over President Trump’s tariffs earlier this month, but the rollercoaster is not over just yet.
Billionaire Hedge Funds
